Treatment of Hormone‐Dependent Cancer with Analogues of Hypothalamic Hormones. Experimental and Clinical Studies^a

Publisher Website

1 May 1987

journal article
Published by Wiley in Annals of the New York Academy of Sciences

Vol. 496 (1) , 602-607
https://doi.org/10.1111/j.1749-6632.1987.tb35820.x

Abstract

No abstract available

This publication has 30 references indexed in Scilit:

Investigation of the combination of the agonist D-Trp-6-LH-RH and the antiandrogen flutamide in the treatment of dunning R-3327H prostate cancer model
The Prostate, 1985
Treatment of advanced prostatic carcinoma with D‐trp‐6‐LH‐RH
The Prostate, 1985
THERAPEUTIC POTENTIAL OF THE LHRH AGONIST, ICI 118630, IN THE TREATMENT OF ADVANCED PROSTATIC CARCINOMA
The Lancet, 1983
TREATMENT OF ADVANCED PROSTATIC CANCER WITH LHRH ANALOGUE ICI 118630: CLINICAL RESPONSE AND HORMONAL MECHANISMS
The Lancet, 1983
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.
BMJ, 1983
Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.
BMJ, 1983
Inhibition of prostate tumors by agonistic and antagonistic analogs of LH‐RH
The Prostate, 1983
Treatment of prostatic cancer with LH-RH analogues
The Prostate, 1983
TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCER
The Lancet, 1982
Effects of a gonadotropin-releasing hormone (GnRH) analogue (A-43818) on7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Histological and endocrine studies
Published by Elsevier ,1977